Capstone Asset Management Co. increased its stake in shares of Medtronic PLC (NYSE:MDT) by 6.9% during the third quarter, Holdings Channel reports. The institutional investor owned 150,531 shares of the medical technology company’s stock after buying an additional 9,676 shares during the period. Capstone Asset Management Co.’s holdings in Medtronic PLC were worth $13,006,000 at the end of the most recent reporting period.

Several other institutional investors also recently made changes to their positions in MDT. Vanguard Group Inc. boosted its position in shares of Medtronic PLC by 1.6% in the second quarter. Vanguard Group Inc. now owns 95,677,703 shares of the medical technology company’s stock valued at $8,301,954,000 after buying an additional 1,489,823 shares in the last quarter. FMR LLC boosted its position in shares of Medtronic PLC by 0.3% in the second quarter. FMR LLC now owns 76,043,424 shares of the medical technology company’s stock valued at $6,598,288,000 after buying an additional 264,681 shares in the last quarter. Massachusetts Financial Services Co. MA boosted its position in shares of Medtronic PLC by 1.9% in the second quarter. Massachusetts Financial Services Co. MA now owns 49,795,064 shares of the medical technology company’s stock valued at $4,320,717,000 after buying an additional 930,313 shares in the last quarter. BlackRock Fund Advisors boosted its position in shares of Medtronic PLC by 3.9% in the second quarter. BlackRock Fund Advisors now owns 20,560,276 shares of the medical technology company’s stock valued at $1,784,015,000 after buying an additional 771,920 shares in the last quarter. Finally, BlackRock Group LTD boosted its position in shares of Medtronic PLC by 0.6% in the second quarter. BlackRock Group LTD now owns 12,657,841 shares of the medical technology company’s stock valued at $1,098,321,000 after buying an additional 79,612 shares in the last quarter. Institutional investors own 80.95% of the company’s stock.

Institutional Ownership by Quarter for Medtronic PLC (NYSE:MDT)

Medtronic PLC (NYSE:MDT) traded down 0.71% during trading on Wednesday, reaching $72.90. 4,156,320 shares of the company traded hands. The company has a market capitalization of $100.60 billion, a P/E ratio of 24.28 and a beta of 1.01. The firm has a 50-day moving average price of $81.50 and a 200-day moving average price of $84.68. Medtronic PLC has a 52 week low of $71.03 and a 52 week high of $89.27.

Medtronic PLC (NYSE:MDT) last released its earnings results on Tuesday, November 22nd. The medical technology company reported $1.12 earnings per share for the quarter, topping the consensus estimate of $1.11 by $0.01. The company had revenue of $7.35 billion for the quarter, compared to the consensus estimate of $7.46 billion. Medtronic PLC had a net margin of 14.63% and a return on equity of 12.36%. Medtronic PLC’s revenue was up 4.1% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.03 EPS. Analysts forecast that Medtronic PLC will post $4.63 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY WARNING: “Capstone Asset Management Co. Increases Position in Medtronic PLC (MDT)” was published by Financial Market News and is the sole property of of Financial Market News. If you are reading this piece of content on another site, it was illegally stolen and reposted in violation of U.S. and international copyright laws. The legal version of this piece of content can be viewed at http://www.financial-market-news.com/capstone-asset-management-co-increases-position-in-medtronic-plc-mdt/1210788/.

MDT has been the topic of a number of recent research reports. Zacks Investment Research upgraded shares of Medtronic PLC from a “hold” rating to a “buy” rating and set a $97.00 price objective on the stock in a report on Tuesday, August 9th. BMO Capital Markets cut their price objective on shares of Medtronic PLC from $94.00 to $87.00 and set an “outperform” rating on the stock in a report on Wednesday, November 23rd. Evercore ISI restated a “buy” rating and issued a $80.00 price objective (down previously from $94.00) on shares of Medtronic PLC in a report on Monday. Deutsche Bank AG restated a “buy” rating on shares of Medtronic PLC in a report on Monday, October 31st. Finally, Vetr upgraded shares of Medtronic PLC from a “buy” rating to a “strong-buy” rating and set a $90.83 price objective on the stock in a report on Tuesday, November 1st. One analyst has rated the stock with a sell rating, six have given a hold rating and twenty have issued a buy rating to the company. The company has an average rating of “Buy” and a consensus target price of $88.19.

In other Medtronic PLC news, Director James T. Lenehan acquired 2,000 shares of the firm’s stock in a transaction on Wednesday, November 23rd. The stock was acquired at an average cost of $73.27 per share, for a total transaction of $146,540.00. The purchase was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, CEO Omar Ishrak sold 61,925 shares of Medtronic PLC stock in a transaction that occurred on Thursday, September 15th. The shares were sold at an average price of $84.93, for a total transaction of $5,259,290.25. Following the sale, the chief executive officer now owns 565,916 shares of the company’s stock, valued at $48,063,245.88. The disclosure for this sale can be found here. Company insiders own 0.25% of the company’s stock.

About Medtronic PLC

Medtronic Public Limited Company (Medtronic) is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group.

5 Day Chart for NYSE:MDT

Want to see what other hedge funds are holding MDT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medtronic PLC (NYSE:MDT).

Receive News & Ratings for Medtronic PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medtronic PLC and related companies with MarketBeat.com's FREE daily email newsletter.